Investor Relations

  1. TOP > 
  2. Investor Relations > 
  3. IR Library > 
  4. Presentation Materials > 
  5. CEO interview: Growth Strategy of Shionogi

CEO interview: Growth Strategy of Shionogi (Full) (November 22,2017)

Play by item

HIV business, and possibility of long-acting injection and prevention in HIV area(0m00s-10m14s)

Future plan of our anti-flu drug(10m15s-18m16s)

Cefiderocol for multidrug-resistant gram-negative bacterial infections(18m17s-23m03s)

Key actions for ADHD(23m04s-30m03s)

Business strategy of Shionogi Inc(30m04s-35m00s)

Shareholder return(35m01s-38m14s)

To achieve sustainable growth of Shionogi beyond 2020(38m15s-46m24s)

page top